Research Progress of CCR and metabolic syndrome and its related diseases

Corresponding author: NiuXiaohan, 470097414@qq.com

DOI: 10.12201/bmr.202501.00048

•  

  Abstract: Metabolic syndrome refers to the underlying mechanism of insulin resistance to the increase of insulin resistance, the body with obesity, hyperlipidemia, hypertension, hyperglycemia as the main manifestations of various metabolic disorders. Serum creatinine to cystatin C ratio is a valid measure of relative muscle mass markers in patients with diseases such as chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, gastric cancer, and sarcopies. Insulin resistance interacts with reduced muscle mass, and promotes each other. This review summarizes the correlation between creatinine and cystatin C ratio and metabolic syndrome and its related diseases.

  Key words: Creatinine to cystatin C ratio; metabolic syndrome; metabolic-associated fatty liver; nephropathy; insulin resistance

  Submit time: 16 January 2025

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• JIA Chen, GONG Yan, HAN Yijing, JIANG Jianan, LIU Weizheng, ZHANG Daxu, LU Wenping. Correlation between psychological stress and metabolic-associated fatty liver disease. 2022. doi: 10.12201/bmr.202204.00003

  Zhang zhenwen. Effects of SGLT2 inhibitors on the metabolic syndrome and its components. 2025. doi: 10.12201/bmr.202503.00002

  Li Xue, Fei Yue, Xu Xiahong. Exploring the relationship between serum ferritin and metabolic-associated fatty liver disease in adolescents based on NHANES database. 2025. doi: 10.12201/bmr.202503.00012

  Liu Wei, Cao Jun, Zhang Xiao Mei, Wang Bao Hua, Zhu Hong Qing. Effects of Shugan Huoxue Yishen decoction on homocysteine, inflammatory factors and endothelial function in patients with metabolic syndrome-related erectile dysfunction. 2025. doi: 10.12201/bmr.202508.00012

  JIANG Yunlan, LI Le, CHEN Hong, WANG Jing, ZHANG Mengjie, BAI Xiaoyu, WU Senlin. Risk factors for metabolic syndrome in hospitalized schizophrenia patients in China: a Meta-analysis. 2025. doi: 10.12201/bmr.202504.00071

  王馨雨, ZHANG Shujuan. Research progress of GLP-2 in non-alcoholic fatty liver disease. 2025. doi: 10.12201/bmr.202502.00018

  Zhang Han, Chu Mengyuan, Xu Kaikai, Xiang Xin, Yan Ying. Progress in Mechanism of Action of Isthmin1 Protein in Polycystic Ovary Syndrome. 2024. doi: 10.12201/bmr.202411.00004

  Liu Lingyan. Ferroptosis and endoplasmic reticulum stress in polycystic ovary syndrome and related potential therapeutic targets. 2025. doi: 10.12201/bmr.202507.00042

  XuHong. Advances in the treatment of osteopenia-seropathic obesity syndrome in the elderly. 2024. doi: 10.12201/bmr.202411.00064

  Wangzhong. Correlation of Serum soluble TREM2 with Acute coronary syndrome in the elderly. 2024. doi: 10.12201/bmr.202412.00086

• ID	Submit time	Number	Download
  1	2025-01-16	10.12201/bmr.202501.00048V1	Download

• Public  Anonymous  To author only Submit Comments